Author: Karl Schmieder

Life Science Leader Reviews What’s Your Bio Strategy

Over at Life Science Leader, editor Rob Wright posted a positive review of What’s Your Bio Strategy? Says Rob: Today we stand on the precipice overlooking a new frontier — the century of biology, and businesses of all kinds need to be prepared to not only embrace what is coming, but have a strategy for how to leverage biology for the betterment of their businesses and the good of the planet. He continues: When I finally had the opportunity to sit down and read it, my … mind … was … blown. Because though the authors interview 25 innovators about how biology is presently impacting a variety of industries, as well as what they think could happen in the very near future, it is even more telling to ponder what they haven’t thought of as being possible, which I found myself doing while reading. As I came across company names (pay attention to highlights) I pondered which might soon rival one of the three “As” of internet commerce (i.e., Alibaba, Alphabet [formerly Google], and Amazon) which have a combined value of about $1.6 trillion. The book discusses concepts such as using DNA for data storage or how the future of fashion may reside in garments being grown in vats (i.e., biofabrication) not woven on looms. To read the full review, click here. The book goes on sale November 3. In...

Read More

Why You’ll Soon Be Using Synthetic Biology to Manufacture Everything

Image: The Factory of Love | Fajar P. Domingo | Source: https://www.pinterest.com/pin/338755203205216484/ As part of our new book “What’s Your Bio Strategy?” we’ve interviewed dozens of entrepreneurs, business leaders and academics working on synthetic biology. The following is an excerpt from one of those interviews. To find out when the book goes on sale subscribe to our newsletter here. The bioeconomy is much bigger than recombinant insulin or genetically modified corn. Increasingly, ordinary industries outside medicine or agriculture will be transformed through the adoption of biological technologies… Intense small scale innovation, coupled with biotechnology, has allowed microbrewers to gain a share of the beer market and be...

Read More

The Genetically Modified Domestic Product

The genetic modification of biological systems already comprises some $350 billion or nearly three percent of the U.S. Gross Domestic product. Rob Carlson, managing director Bioeconomy Capital and author of Biology is Technology terms this the “Genetically Modified Domestic Product.”   This bioeconomy includes crops, drugs, fuels, industrial enzymes and materials. When he published Biology is Technology, Carlson pointed out: Current biotechnology demonstrates impressive and disproportionate economic performance despite the fact that the underlying technology is presently immature compared with other sectors of the economy. “Impressive and disproportionate economic performance” means that using biotechnology enables fewer people to create...

Read More

Every Company is a Biology Company

Every Company Is a Biology Company We believe every company is a biotechnology company. Synthetic biology is poised to impact nearly every aspect of our lives, from the sheets we sleep on to the clothes we wear, the foods we eat, the ways we travel, the places we live and the environment that surrounds us. It will enable and facilitate travel beyond earth. The blog posts that will follow are about how synthetic biology is already displacing existing manufacturing methods, how the field is rapidly advancing and why companies need to have a strategy for incorporating biology into their...

Read More